Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?

BACKGROUND: Cardiovascular disease is a serious complication in patients with dysglycaemia, defined as either type 2 diabetes or impaired glucose tolerance. Research focusing on the identification of potential markers for atherothrombotic disease in these subjects is warranted. The antiphospholipid...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrannini, Giulia, Svenungsson, Elisabet, Kjellström, Barbro, Elvin, Kerstin, Grosso, Giorgia, Näsman, Per, Rydén, Lars, Norhammar, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607409/
https://www.ncbi.nlm.nih.gov/pubmed/32506943
http://dx.doi.org/10.1177/1479164120922123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607409/
https://www.ncbi.nlm.nih.gov/pubmed/32506943
http://dx.doi.org/10.1177/1479164120922123

Ejemplares similares